Pharmaceuticals · Italy
Top 10 Pharmaceuticals markets in Italy
The fastest-growing and largest of the 20 sized Pharmaceuticals markets in Italy, 2023 to 2033, with active clinical trials.
Top 10 Pharmaceuticals markets in ItalyThe fastest-growing and largest of the 20 sized Pharmaceuticals markets in Italy, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $886 Mn | $7.9 Bn | 24.4% | 18 |
| 2 | Cell Based Immunotherapy | $398 Mn | $3 Bn | 22.5% | 1,614 |
| 3 | Cannabidiol (CBD) | $529 Mn | $2.4 Bn | 16.3% | 12 |
| 4 | Cannabis | $814 Mn | $2.8 Bn | 13% | 10 |
| 5 | Atopic Dermatitis Drugs | $270 Mn | $815 Mn | 11.7% | 27 |
| 6 | Oncology/Cancer Drugs | $4.2 Bn | $9.1 Bn | 7.9% | 1,804 |
| 7 | Anti-Aging | $2.1 Bn | $4.4 Bn | 7.6% | 96 |
| 8 | Diabetes Management | $1.9 Bn | $3.5 Bn | 6.6% | 130 |
| 9 | Alzheimer Drugs | $120 Mn | $222 Mn | 6.3% | 72 |
| 10 | Contraceptives Drugs | $605 Mn | $1.1 Bn | 6.3% | 1 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $4.2 Bn | $9.1 Bn | 7.9% | 1,804 |
| 2 | Anti-Aging | $2.1 Bn | $4.4 Bn | 7.6% | 96 |
| 3 | Diabetes Management | $1.9 Bn | $3.5 Bn | 6.6% | 130 |
| 4 | Gastrointestinal Drugs | $1.3 Bn | $1.9 Bn | 4.1% | 694 |
| 5 | Asthma & COPD Drugs | $1.2 Bn | $1.7 Bn | 3.5% | 57 |
| 6 | Biosimilars | $886 Mn | $7.9 Bn | 24.4% | 18 |
| 7 | Cannabis | $814 Mn | $2.8 Bn | 13% | 10 |
| 8 | HIV Drugs | $720 Mn | $1.2 Bn | 5.3% | 24 |
| 9 | Contraceptives Drugs | $605 Mn | $1.1 Bn | 6.3% | 1 |
| 10 | Cancer Supportive Care Drugs | $595 Mn | $898 Mn | 4.2% | 261 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Biosimilars grows fastest, at 24.4% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (22.5%).
Oncology/Cancer Drugs is the largest, worth about $4.2 Bn in 2023 and $9.1 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
UK
Germany
France
Spain